Serena Bugatti

Rituximab versus tocilizumab in anti-TNF inadequate responder patients with rheumatoid arthritis (R4RA): 16-week outcomes of a stratified, biopsy-driven, multicentre, open-label, phase 4 randomised controlled trial

Frances Humby, Patrick Durez, Maya H Buch et al. · The Lancet · 2021 · 315 citations · Full text

Life Sciences, Immunology, Pharmacotherapy +17

Rituximab versus tocilizumab in rheumatoid arthritis: synovial biopsy-based biomarker analysis of the phase 4 R4RA randomized trial

Felice Rivellese, Anna E. A. Surace, Katriona Goldmann et al. · Nature Medicine · 2022 · 279 citations · Full text

Life Sciences, Immunology, Internal Medicine +17

The novel cytokine interleukin-36α is expressed in psoriatic and rheumatoid arthritis synovium

Silke Frey, Anja Derer, Maria-Elena Messbacher et al. · Annals of the Rheumatic Diseases · 2012 · 168 citations · Full text

Medicine, Immunology, Oncology +17

Autoantibody profile in rheumatoid arthritis during long-term infliximab treatment

Francesca Bobbio‐Pallavicini, Claudia Alpini, Roberto Caporali et al. · Arthritis Research & Therapy · 2004 · 163 citations · Full text

Life Sciences, Immunology, Pharmacology +17

Anti-citrullinated protein antibodies and high levels of rheumatoid factor are associated with systemic bone loss in patients with early untreated rheumatoid arthritis

Serena Bugatti, Laura Bogliolo, B. Vitolo et al. · Arthritis Research & Therapy · 2016 · 111 citations · Full text

Medicine, Immunology, Internal Medicine +17